Aerogen's pioneering aerosol drug delivery technology is transforming emergency medicine in hospitals worldwide. Silent and quick to set up, Aerogen devices deliver significantly more medication in half the time.1
reduction in ED admission rates2 *
achieved symptom control with 2.5mg albuterol dose2 *
reduction in ED median length of stay2 *
* when compared to a small volume jet nebuliser
"We saw a decrease in admissions, an increase in discharge and a decrease in length of stay."2
Patients treated with Aerogen Ultra experienced a 32% reduction in admission rates, associated with a 30% increase in discharge rates, positively affecting ED throughput.*
*when compared to a small volume of jet nebuliser
Patient LOS is a critical factor in every Emergency Department. The Aerogen Ultra demonstrated a 37 minute reduction in LOS per patient, reducing from a 4.79 hours average LOS to 4.17 hours.*
* when compared to a small volume of jet nebuliser
I would like to book a demo and see how Aerogen can enhance care in my hospital.
1 Hickin S, Mac Loughlin R, Sweeney L, Tatham A and Gldwani S. Comparison of mesh nebuliser versus jet nebuliser in simulated adults with chromic obstructive pulmonary disease. Publication at the College of Emergency Medicine Clincial Excellence Conference. 2004.
2 Dunne RB and Shortt S. Comparison of bronchodilator administration with vibrating mesh nebulizer and standard jet nebulizer in the emergency department. The American journal of emergency medicine. 2017